Biohaven licenses Kv7 epilepsy platform to SK Biopharma for up to $795M

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. ZS
2. LULU
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. NVDA
9. CIEN
10. GWRE

Go back to Biohaven licenses Kv7 epilepsy platform to SK Biopharma for up to $795M
(NYSE: BHVN) Delayed: 15.69 -0.17 (1.07%)
Previous Close $15.86    52 Week High $ 
Open $15.52    52 Week Low $ 
Day High $15.81    P/E N/A 
Day Low $15.21    EPS $ 
Volume 1,901,049